What is the Role of Hyperosmolar Therapy in Hemispheric Stroke Patients?

Nathan Mohney, Omar Alkhatib, Sebastian Koch, Kristine H O'Phelan, Amedeo Merenda

Research output: Contribution to journalReview article

Abstract

The role of hyperosmolar therapy (HT) in large hemispheric ischemic or hemorrhagic strokes remains a controversial issue. Past and current stroke guidelines state that it represents a reasonable therapeutic measure for patients with either neurological deterioration or intracranial pressure (ICP) elevations documented by ICP monitoring. However, the lack of evidence for a clear effect of this therapy on radiological tissue shifts and clinical outcomes produces uncertainty with respect to the appropriateness of its implementation and duration in the context of radiological mass effect without clinical correlates of neurological decline or documented elevated ICP. In addition, limited data suggest a theoretical potential for harm from the prophylactic and protracted use of HT in the setting of large hemispheric lesions. HT exerts effects on parenchymal volume, cerebral blood volume and cerebral perfusion pressure which may ameliorate global ICP elevation and cerebral blood flow; nevertheless, it also holds theoretical potential for aggravating tissue shifts promoted by significant interhemispheric ICP gradients that may arise in the setting of a large unilateral supratentorial mass lesion. The purpose of this article is to review the literature in order to shed light on the effects of HT on brain tissue shifts and clinical outcome in the context of large hemispheric strokes, as well as elucidate when HT should be initiated and when it should be avoided.

Original languageEnglish (US)
JournalNeurocritical Care
DOIs
StatePublished - Jan 1 2019

Fingerprint

Stroke
Intracranial Hypertension
Cerebrovascular Circulation
Intracranial Pressure
Therapeutics
Uncertainty
Guidelines
Brain

Keywords

  • Edema
  • Hemispheric infarct
  • Herniation
  • Hyperosmolar therapy
  • Ischemic stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Critical Care and Intensive Care Medicine

Cite this

What is the Role of Hyperosmolar Therapy in Hemispheric Stroke Patients? / Mohney, Nathan; Alkhatib, Omar; Koch, Sebastian; O'Phelan, Kristine H; Merenda, Amedeo.

In: Neurocritical Care, 01.01.2019.

Research output: Contribution to journalReview article

@article{2d33fcc0c1564e93b8b4d80477445b45,
title = "What is the Role of Hyperosmolar Therapy in Hemispheric Stroke Patients?",
abstract = "The role of hyperosmolar therapy (HT) in large hemispheric ischemic or hemorrhagic strokes remains a controversial issue. Past and current stroke guidelines state that it represents a reasonable therapeutic measure for patients with either neurological deterioration or intracranial pressure (ICP) elevations documented by ICP monitoring. However, the lack of evidence for a clear effect of this therapy on radiological tissue shifts and clinical outcomes produces uncertainty with respect to the appropriateness of its implementation and duration in the context of radiological mass effect without clinical correlates of neurological decline or documented elevated ICP. In addition, limited data suggest a theoretical potential for harm from the prophylactic and protracted use of HT in the setting of large hemispheric lesions. HT exerts effects on parenchymal volume, cerebral blood volume and cerebral perfusion pressure which may ameliorate global ICP elevation and cerebral blood flow; nevertheless, it also holds theoretical potential for aggravating tissue shifts promoted by significant interhemispheric ICP gradients that may arise in the setting of a large unilateral supratentorial mass lesion. The purpose of this article is to review the literature in order to shed light on the effects of HT on brain tissue shifts and clinical outcome in the context of large hemispheric strokes, as well as elucidate when HT should be initiated and when it should be avoided.",
keywords = "Edema, Hemispheric infarct, Herniation, Hyperosmolar therapy, Ischemic stroke",
author = "Nathan Mohney and Omar Alkhatib and Sebastian Koch and O'Phelan, {Kristine H} and Amedeo Merenda",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12028-019-00782-9",
language = "English (US)",
journal = "Neurocritical Care",
issn = "1541-6933",
publisher = "Humana Press",

}

TY - JOUR

T1 - What is the Role of Hyperosmolar Therapy in Hemispheric Stroke Patients?

AU - Mohney, Nathan

AU - Alkhatib, Omar

AU - Koch, Sebastian

AU - O'Phelan, Kristine H

AU - Merenda, Amedeo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The role of hyperosmolar therapy (HT) in large hemispheric ischemic or hemorrhagic strokes remains a controversial issue. Past and current stroke guidelines state that it represents a reasonable therapeutic measure for patients with either neurological deterioration or intracranial pressure (ICP) elevations documented by ICP monitoring. However, the lack of evidence for a clear effect of this therapy on radiological tissue shifts and clinical outcomes produces uncertainty with respect to the appropriateness of its implementation and duration in the context of radiological mass effect without clinical correlates of neurological decline or documented elevated ICP. In addition, limited data suggest a theoretical potential for harm from the prophylactic and protracted use of HT in the setting of large hemispheric lesions. HT exerts effects on parenchymal volume, cerebral blood volume and cerebral perfusion pressure which may ameliorate global ICP elevation and cerebral blood flow; nevertheless, it also holds theoretical potential for aggravating tissue shifts promoted by significant interhemispheric ICP gradients that may arise in the setting of a large unilateral supratentorial mass lesion. The purpose of this article is to review the literature in order to shed light on the effects of HT on brain tissue shifts and clinical outcome in the context of large hemispheric strokes, as well as elucidate when HT should be initiated and when it should be avoided.

AB - The role of hyperosmolar therapy (HT) in large hemispheric ischemic or hemorrhagic strokes remains a controversial issue. Past and current stroke guidelines state that it represents a reasonable therapeutic measure for patients with either neurological deterioration or intracranial pressure (ICP) elevations documented by ICP monitoring. However, the lack of evidence for a clear effect of this therapy on radiological tissue shifts and clinical outcomes produces uncertainty with respect to the appropriateness of its implementation and duration in the context of radiological mass effect without clinical correlates of neurological decline or documented elevated ICP. In addition, limited data suggest a theoretical potential for harm from the prophylactic and protracted use of HT in the setting of large hemispheric lesions. HT exerts effects on parenchymal volume, cerebral blood volume and cerebral perfusion pressure which may ameliorate global ICP elevation and cerebral blood flow; nevertheless, it also holds theoretical potential for aggravating tissue shifts promoted by significant interhemispheric ICP gradients that may arise in the setting of a large unilateral supratentorial mass lesion. The purpose of this article is to review the literature in order to shed light on the effects of HT on brain tissue shifts and clinical outcome in the context of large hemispheric strokes, as well as elucidate when HT should be initiated and when it should be avoided.

KW - Edema

KW - Hemispheric infarct

KW - Herniation

KW - Hyperosmolar therapy

KW - Ischemic stroke

UR - http://www.scopus.com/inward/record.url?scp=85069738757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069738757&partnerID=8YFLogxK

U2 - 10.1007/s12028-019-00782-9

DO - 10.1007/s12028-019-00782-9

M3 - Review article

AN - SCOPUS:85069738757

JO - Neurocritical Care

JF - Neurocritical Care

SN - 1541-6933

ER -